Capricor Therapeutics Inc (CAPR) Reports Encouraging Year-End Financials and Advances in DMD Therapy
Company Poised for Pivotal Trial Results and FDA Discussions in 2024
Source: yahoo.com
Stay updated with breaking news from Exosome Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company Poised for Pivotal Trial Results and FDA Discussions in 2024
Israeli-Canadian NurExone Biologic is developing groundbreaking exosome technology for treatment of spinal cord injuries and additional indications
Investegate announcements from ReNeuron Group plc, Positive iPSC data presented at conference
Co-Founder & CEO Jordan R. Plews, Ph.D. Presents Key Considerations For an Emerging New Class of Regenerative SkincareNEWPORT BEACH, Calif., Nov. ...
Investegate announcements from ReNeuron Group plc, ReNeuron to present new data at Exosome conference